Prédispositions héréditaires au cancer du sein : après BRCA1 et BRCA2, quel(s) autre(s) gène(s) ? = Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?BONADONA, Valérie; LASSET, Christine.Bulletin du cancer. 2003, Vol 90, Num 7, pp 587-594, issn 0007-4551, 8 p.Article

Prise en charge des femmes à risque héréditaire de cancer du sein : indications et modalités du dépistage par mammographie = Medical management of women with inherited predisposition to breast cancer: indications and procedures for mammographic screeningLASSET, Christine; BONADONA, Valérie.Bulletin du cancer. 2001, Vol 88, Num 7, pp 677-686, issn 0007-4551Article

Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) methodBONAÏTI, Bernard; BONADONA, Valérie; PERDRY, Hervé et al.European journal of human genetics. 2011, Vol 19, Num 2, pp 173-179, issn 1018-4813, 7 p.Article

Nouveau système de score pour le diagnostic des prédispositions aux cancers du sein et de l'ovaire associées à BRCA1/2 = A new scoring system for the diagnosis of BRCA1/2 associated breast-ovarian cancer predispositionBONAÏTI, Bernard; ALARCON, Flora; BONADONA, Valérie et al.Bulletin du cancer. 2011, Vol 98, Num 7, pp 779-795, issn 0007-4551, 17 p.Article

Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for B RCA1/2 mutationsJULIAN-REYNIER, Claire; MANCINI, Julien; MOURET-FOURME, Emmanuelle et al.European journal of human genetics. 2011, Vol 19, Num 5, pp 500-506, issn 1018-4813, 7 p.Article

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeBONADONA, Valérie; BONAITI, Bernard; COLAS, Chrystelle et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 22, pp 2304-2310, issn 0098-7484, 7 p.Article

Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and reviewBONADONA, Valérie; DUSSART-MOSER, Sophie; RAUDRANT, Daniel et al.Breast cancer research and treatment. 2007, Vol 101, Num 2, pp 233-245, issn 0167-6806, 13 p.Article

Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: Reactions and behavior after the disclosure of a positive test resultBONADONA, Valérie; SALTEL, Pierre; PUISIEUX, Alain et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 1, pp 97-104, issn 1055-9965Article

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersPHILLIPS, Kelly-Anne; MILNE, Roger L; BUYS, Saundra S et al.Journal of clinical oncology. 2013, Vol 31, Num 25, pp 3091-3099, issn 0732-183X, 9 p.Article

Estimating cancer risk in HNPCC by the GRL methodALARCONL, Flora; LASSET, Christine; CARAYOL, Jérome et al.European journal of human genetics. 2007, Vol 15, Num 8, pp 831-836, issn 1018-4813, 6 p.Article

RAD51 135G→C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers : Results from a Combined Analysis of 19 StudiesANTONIOU, Antonis C; SINILNIKOVA, Olga M; COUPIER, Isabelle et al.American journal of human genetics. 2007, Vol 81, Num 6, pp 1186-1200, issn 0002-9297, 15 p.Article

Significant contribution of germline BRCA2 rearrangements in male breast cancer familiesTOURNIER, Isabelle; BRESSAC-DE PAILLERETS, Brigitte; LORTHOLARY, Alain et al.Cancer research (Baltimore). 2004, Vol 64, Num 22, pp 8143-8147, issn 0008-5472, 5 p.Article

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testingMANCINI, Julien; NOGUES, Catherine; LASSET, Christine et al.European journal of cancer (1990). 2006, Vol 42, Num 7, pp 871-881, issn 0959-8049, 11 p.Article